Research programme: Sjogren's syndrome diagnostics - Biogen/Oklahoma Medical Research Foundation
Latest Information Update: 29 Oct 2015
At a glance
- Originator Biogen
- Developer Biogen; Oklahoma Medical Research Foundation
- Class Diagnostic agents
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Sjogren's syndrome
Most Recent Events
- 22 Oct 2015 Early research in Sjogren's syndrome (Diagnosis) in USA (unspecified route)